Adam E. Jakus

eXIthera Pharmaceuticals, Inc. develops and manufactures stroke prevention and antithrombosis drugs. Its drugs are based on the pathophysiological role of Factor XI in the initiation of intravascular thrombi without causing undue bleeding. The firm’s drug candidates are small, orally active, and highly selective Factor XI inhibitors. The company was founded by Neil J. Hayward and Frans L. Stassen in 2012 and is headquartered in Westborough, MA.

The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010.

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses

ARCH Development Partners LLC is an Independent Venture Capital firm founded in 2001. The firm is headquartered in Chicago.

Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL.

BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada.

Ryder Last Mile, Inc. provides delivery logistics solutions. It also provides door-to-door delivery and oversized items. The firm specializes in touch white glove delivery services for North American retail brands across a variety of consumer product segments, including furniture, bedding, appliances, and electronics. The company was founded in 1970 and is headquartered in New Albany, OH.

SanoGene Therapeutics, Inc. operates as a biotechnology company. Its RNA interference (RNAi) technology to develop biopharmaceutical products for incurable cancers. The company was founded by Caralynn Nowinski Collens and Chirag Patel in 2006 and is headquartered in Chicago, IL.

Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA.

UI LABS operates as a research and commercialization agency. The non-profit company is based in Chicago, IL. The company was founded by Caralynn Nowinski Collens.

Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA.

KdT Ventures LLC (KdT Ventures) is a venture capital firm founded in 2017 by Cain Mcclary . The firm is headquartered in Austin, Texas.

Kytopen Corp. engages in the provision of technology solutions. It develops genetically engineered cells that modifies microorganisms. The company was founded by Paulo A. Gracia and Cullen R. Buie in 2017 and is headquartered in Cambridge, MA.

Combined Therapeutics, Inc. engages in biotechnology industry group. The company was founded by Romain Micol, Robert Langer, and Dan Anderson in and is headquartered in North Cambridge, MA.

Avenge Bio, Inc. is an oncology-focused biotechnology company based in the United States. The American company develops cell-based immunotherapeutic products for the treatment of solid tumors using its proprietary Lococyte™ platform. The platform delivers engineered cells to the local tumor environment, generating high concentrations of immune effector molecules in proximity to the tumor, which initiates a robust, local, and durable systemic immune response while avoiding toxicities associated with systemic immunotherapies. Avenge's most advanced product candidate, AVB-001, produces native IL-2 immunotherapy and is initially being studied in metastatic peritoneal cancers such as ovarian cancer. The company has additional pipeline candidates for the treatment of a wide range of cancers, including pancreatic, lung, and breast cancers. Avenge was founded in 2019 by Paul Kevin Wotton and Michael Thomas Heffernan, with Heffernan serving as CEO since incorporation.

Van Wickle Ventures (VWV) is an Independent Venture Capital firm. The firm is headquartered in Providence, Rhode Island. It is founded by John Diorio in 2018.

Cypris Materials, Inc. is a company that is focused on developing the next generation of color. The company is based in Berkeley, CA. The company aims to improve sustainability, broaden the color gamut, and make manufacturing and formulation easier, all without using pigments, dyes, metals, or expensive engineering processes. The company was founded in 2010 by Raymond Weitekamp, Garret Miyake, Nobel Laureate, Ryan Pearson, Robert Grubbs, Matthew Ryan. Ryan Pearson has been the CEO since 2010.